iBionext
Jean-Christophe Dantonel is a seasoned professional with extensive experience in the health and biotechnology sectors. Currently serving as Managing Partner at iBionext and Board Member at both Vect-Horus and Tilak Healthcare, Jean-Christophe previously held board positions at EUROAPI and directed health and biotechnology initiatives at the Secrétariat général pour l'investissement for over a decade. With a strong academic background, including a Ph.D. in Genetics from the University of Strasbourg and an MBA from Sciences Po, Jean-Christophe has demonstrated expertise in international project management and oncology. Significant achievements include leading clinical trials, publishing in top scientific journals, and contributing to biotech project strategies and negotiations throughout a diverse career.
This person is not in any teams
This person is not in any offices
iBionext
VENTURE BUILDER & GROWTH FUND Building and financing healthtech start-ups from creation to growth to transform innovation into products. OUR ACHIEVEMENTS - IBIONEXT IN NUMBERS 9 companies created 600M+ Euros raised collectively by iBionext and its companies since 2012 370+ highly qualified jobs created OUR APPROACH Spot: We provide a structural ecosystem to source, mature, finance and build innovative technologies. Boost : We gather experimented professionals to turn disruptive ideas into start-ups and lead their financing. Grow: We support the growth of our companies to maximise their value and build international champions.